Tune Therapeutics

Developer of cell and gene therapy by using the epigenomic platform

placeSeattle, Washington, United States calendar_todayFounded 2009 groups89 employees language tunetx.com

Social engagement

Social engagement: 23.9K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

10 investors on record; lead investors include New Enterprise Associates, Emerson Collective.

Investor typeCountShare
Venture capital770%
Other / undisclosed330%

Recent activity

5 Jun 2026
Milestone
regulatory
30 May 2026
Milestone
regulatory
5 May 2026
Event
regulatory
Coming soon